HALT – MS – more data of HSCT Effectiveness

A new study on autologous HSCT in MS appeared – the data shows excellent results at 3 years post treatment. The maximum follow up for active RRMS patients  is over 66 months and around 90% of patients will not have EDSS progression – patients that had active MS prior to AHSCT and had relapsed on two previous therapies.

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s